Compounding: Groups Tell FDA To Drop “Traditional” and “Non-Traditional” Categories
Executive Summary
Stakeholders say it would create more confusion in the pharmacy and regulatory community; they also spar over whether volume, other criteria should be imposed to distinguish compounding types.